Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, February 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter: 4 X users
patent: 1 patent

facebook: 1 Facebook page

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Patents Facebook Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

NOVEL RAS INHIBITORS

Application WO-2023242102-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.